Eleusis is dedicated to transforming psychedelics into medicines for the treatment of depression and other major unmet needs. Here is our story:
Eleusis
Biotechnology Research
London, England 4,297 followers
Transforming Psychedelics into Medicines
About us
Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design. The company’s comprehensive discovery and development capabilities, together with Andala’s care delivery platform, enable it to target a broad spectrum of unmet needs within psychiatry and beyond psychiatry.
- Website
-
http://www.eleusisltd.com
External link for Eleusis
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2013
Locations
-
Primary
Get directions
50 Grosvenor Hill
London, England W1K 3QT, GB
-
Get directions
222 Broadway
New York, NY 10038, US